Description: Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. It offers SALONPAS pain relief products in the form of patches, sprays, gels, creams, liniments, and lotions; SALONSIP gel patches and heat pads; ByeBye-FEVER, a cooling gel sheet for fever discomfort in babies, children, and adults; Lifecella facial and gel sheet masks; and MOHRUS and KEPLAT pain relieving patches. The company sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Exchange: OTCGREY
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | February |
| Full Time Employees: | 2751 |